Opdivo Qvantig is approved for solid tumors, including melanoma, renal cell carcinoma, and non-small cell lung cancer. The ...

Tevimbra approved for HER2-negative gastric or gastroesophageal junction adenocarcinoma with PD-L1 expression, in combination ...

We, survivors, often express our gratitude for life, love, support and research, but what about the patients who do not ...

An MPN advocate used his personal experiences to inform his dedication to patient-centered research and support programs for ...

CURE® highlights some of the top stories from SABCS, including those focused on older and younger patients with breast cancer ...

An expert spoke with CURE® about the importance of information that can be gained from genetic testing for patients with ...

When we got back from the beach, fall was in the air, and we both were back in the reality of doctor appointments, CT scans, ...

A patient advocate discusses the difficulties of finding and participating in clinical trials for MPNs, and the impact on ...

With breakthroughs from melanoma to pancreatic cancer, this has been a year of great promise in the field of cancer vaccines.

Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses ...

Monjuvi plus Revlimid and Rituxan demonstrated improved progression-free survival for patients with relapsed or refractory ...

In February 2024, the FDA approved Onivyde (irinotecan liposome) with oxaliplatin, fluorouracil and leucovorin for the ...